SCHEMBL6941241

SCHEMBL6941241

C#Cc1ccc(Nc2c(C(=O)O)cc(F)c(F)c2F)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 12/20 0.52
MAP2K2 P36507 3/20 0.41
IDO1 P14902 1/20 0.37
CLCN2 P51788 1/20 0.36
FABP3 P05413 1/20 0.36
FABP4 P15090 1/20 0.36
RAF1 P04049 1/20 0.35
PDGFRB P09619 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A1 P68400 1/20 0.35
CSNK2A3 Q8NEV1 1/20 0.35
AURKC Q9UQB9 1/20 0.35
CAMK2A Q9UQM7 1/20 0.35
FTO Q9C0B1 2/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
TAS2R14 Q9NYV8 1/20 0.35
ABCB11 O95342 1/20 0.34
PTGS1 P23219 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6945177 0.88 MAP2K1 (0.45) MAP2K1MAP2K2RAF1PDGFRBCSNK2A2
SCHEMBL6944105 0.88 MAP2K1 (0.47) MAP2K1MAP2K2CLCN2FABP3FABP4
SCHEMBL6948257 0.88 MAP2K1 (0.68) MAP2K1MAP2K2CLCN2RAF1PDGFRB
SCHEMBL6944532 0.85 MEN1 (0.47) MAP2K1MAP2K2IDO1CLCN2
SCHEMBL4853099 0.81 MAP2K1 (0.77) MAP2K1MAP2K2IDO1RAF1PDGFRB
SCHEMBL6944537 0.79 MAP2K1 (0.61) MAP2K1MAP2K2RAF1PDGFRBCSNK2A2
SCHEMBL6946169 0.79 MAP2K1 (0.53) MAP2K1MAP2K2RAF1PDGFRBCSNK2A2
SCHEMBL6946643 0.78 MAP2K1 (0.42) MAP2K1MAP2K2RAF1PDGFRBCSNK2A2
SCHEMBL5427155 0.78 MAP2K1 (0.46) MAP2K1MAP2K2IDO1
SCHEMBL6951921 0.78 CLCN2 (0.51) MAP2K1MAP2K2CLCN2FABP3FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202724-B1 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER LAMBERT CO (US) 2003-10-01 EP claimed
JP-2003504401-A 2003-02-04 JP claimed
EP-1202724-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2002-05-08 EP claimed
EP-1150950-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2001-11-07 EP claimed
WO-2001005393-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-01-25 WO claimed
WO-2000041505-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2000-07-20 WO claimed
EP-1202724-B1 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER LAMBERT CO (US) 2003-10-01 EP disclosed
EP-1202724-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2002-05-08 EP disclosed
EP-1150950-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2001-11-07 EP disclosed
WO-2001005393-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-01-25 WO disclosed
WO-2000041505-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2000-07-20 WO disclosed